1, 2, 4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents

Abstract

A method of using 1,2,4-benzotriazine oxides, some of which are novel compounds, as radiosensitizers and selective cytotoxic agents is disclosed. These compounds are shown to specifically radiosensitive hypoxic tumor cells. Some are additionally disclosed to be useful as specific cytotoxic agents for these cells. They also show an unexpected ability to radiosensitize aerobic cells following or preceding a hypoxic incubation of the cells with the drug. This provides a basis for selective radiosensitization of tumors compared to normal cells. A novel method for preparing the 1,2,4-benzotriazine oxides is also disclosed.

What is claimed is:  
     
       1. A method of selectively killing hypoxic tumor cells sensitive to the compounds of the formula in a host comprising administering to said host an effective amount of a pharmaceutical composition comprising a compound of the formula                    
       wherein 
       X is C 1 -C 4  hydrocarbyl;  
       n is 1; and  
       Y 1  and Y 2  are independently either H; nitro, halogen; methoxy; hydrocarbyl (1-14C) including cyclic and unsaturated hydrocarbyl, optionally substituted with 1 or 2 substituents selected from the group consisting of halogen, hydroxy, epoxy, alkoxy (1-4C), alkylthio (1-4C), primary amino (NH 2 ), lower alkyl (1-4C) secondary amino, dialkyl (1-4C) tertiary amino, dialkyl (1-4C) tertiary amino where the two alkyls are linked together to produce a morpholino, pyrrolidino or piperidino, acyloxy (1-4C), acylamido (1-4C) and thio analogs thereof, acetylaminoalkyl (1-4C), carboxy, alkoxycarbonyl (1-4C), carbamyl, alkylcarbamyl (1-4C), alkylsulfonyl (1-4C) or alkylphosphonyl (1-4C), wherein the hydrocarbyl can optionally be interrupted by a single ether (—O—) linkage; or wherein Y 1  and Y 2  are independently either morpholino, pyrrolidino, piperidino, NH2, NHR′, NR′R′O(CO)R′, NH(CO)R′, O(SO)R′, or O(POR′)R′ in which R′ is a hydrocarbyl (1-4C) which may be substituted with OH, NH2, alkyl-(1-4C) secondary amino, dialkyl (1-4C) tertiary amino, morpholino, pyrrolidino, piperidino, alkoxy (1-4C), or halogen substituents, or a pharmacologically acceptable salt of said compound.  
     
     
       2. The method of  claim 1 , wherein Y 1  and Y 2  are both H. 
     
     
       3. The method of  claim 1 , wherein Y 1  is H and Y 2  is nitro. 
     
     
       4. The method of  claim 1  wherein said compound is 3-methyl-1,2,4-benzotriazine 1,4-dioxide. 
     
     
       5. The method of  claim 1  wherein Y 1  and Y 2  are independently either H, NH2 or methoxy. 
     
     
       6. The method of  claim 5  wherein one of Y 1  and Y 2  is hydrogen and the other is NH 2  or methoxy. 
     
     
       7. The method of  claim 1  wherein said compound is chosen from 
       3-ethyl-1,2,4-benzotriazine 1,4-dioxide;  
       3-propyl-1,2,4-benzotriazine 1,4-dioxide;  
       6(7)-amino-3-methyl-1,2,4-benzotriazine 1,4-dioxide;  
       6(7)-amino-3-ethyl-1,2,4-benzotriazine 1,4-dioxide; and  
       6(7)-methoxy-3-methyl-1,2,4-benzotriazine 1,4-dioxide.